AnalystsJames CondulisJames Condulis's Stock Forecasts
AnalystsJames Condulis
Sectors:
Industries:
Analyst Ranking
Bottom 17%
#4421 out of 5290 analysts
Average Return
-3.02%
Win Rate
25%3 out of 12
Risk vs Reward
Poor
Good
James Condulis's 5 best and worst ratings
James Condulis Analyst Color
Get additional color on James Condulis's coverage of popular stocks
James Condulis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Fulcrum Therapeutics IncFULC | 1 | Hold | $3.00 | -18.70% | Downgrades | 5 days ago |
Cytokinetics IncCYTK | 3 | Strong Buy | $108.00 | +51.09% | Maintains | a month ago |
Mirum Pharmaceuticals IncMIRM | 1 | Strong Buy | $130.00 | +39.07% | Maintains | a month ago |
Tectonic Therapeutic IncTECX | 1 | Strong Buy | $75.00 | +158.62% | Initiates Coverage On | 2 months ago |
Amylyx Pharmaceuticals IncAMLX | 1 | Strong Buy | $21.00 | +57.66% | Initiates Coverage On | 3 months ago |
Aardvark Therapeutics IncAARD | 2 | Hold | $6.00 | +63.04% | Downgrades | 3 months ago |
Newamsterdam Pharma Co NvNAMS | 2 | Strong Buy | $50.00 | +58.63% | Maintains | 6 months ago |
X4 Pharmaceuticals IncXFOR | 1 | Strong Buy | $10.00 | +161.10% | Maintains | 6 months ago |
Soleno Therapeutics IncSLNO | 2 | Strong Buy | $108.00 | N/A | Maintains | a year ago |
Edgewise Therapeutics IncEWTX | 1 | Hold | $30.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.